Micropaque Suspension

Barium sulfate, the active ingredient in Micropaque, is a contrast agent presented as a suspension for oral and rectal use. It provides a radiopaque coating of the gastrointestinal tract, enabling clear visualization of the GI lumen during X‑ray based imaging procedures in patients undergoing diagnostic radiology. GNH USA supplies Micropaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Micropaque is a barium‑based contrast medium used in gastrointestinal imaging procedures. - Barium studies of the esophagus, stomach, and intestines: enables detailed radiographic visualization of the upper and lower GI lumen. - Contrast imaging of the gastrointestinal tract: provides radiopaque coating for X‑ray examinations of the entire GI tract. - Upper GI series: delineates mucosal patterns and structural abnormalities during fluoroscopic assessment.

Micropaque may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea or mild vomiting: transient discomfort following oral administration. - Abdominal cramping or discomfort: due to the presence of a dense suspension in the GI tract. - Constipation or altered bowel movements: may occur if adequate hydration is not maintained.

Serious or Rare Side Effects: - Aspiration pneumonia: risk if the suspension is inhaled, especially in patients with swallowing difficulties. - Bowel obstruction or impaction: can occur in patients with pre‑existing strictures or motility disorders. - Severe allergic reaction: rare anaphylactoid response presenting with rash, bronchospasm, or hypotension.

When using Micropaque, clinicians should observe specific safety measures to minimize risks. - Assess for gastrointestinal obstruction: avoid use in patients with known or suspected bowel blockage. - Check for perforation risk: contraindicated if gastrointestinal perforation is suspected. - Review allergy history: avoid in patients with known hypersensitivity to barium sulfate. - Consider alternative imaging in pregnancy: use only when diagnostic benefit outweighs potential fetal exposure. - Ensure adequate hydration: encourage fluid intake after administration to reduce constipation. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Barium sulfate can affect the absorption of certain orally administered drugs, requiring careful timing.

Major Interactions (Avoid): - Tetracycline and quinolone antibiotics: may bind barium, markedly reducing antibiotic absorption. - Levothyroxine (thyroid hormone): barium can impair its gastrointestinal uptake, diminishing therapeutic effect.

Moderate Interactions (Monitor Closely): - Oral iron supplements: may experience reduced absorption when taken concurrently. - Calcium or multivitamin preparations: can interfere with barium uptake, potentially decreasing imaging quality. - Radiopharmaceutical agents: barium presence may alter interpretation of concurrent nuclear medicine studies.